Swiss National Bank - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$535,500
-49.1%
225,000
+2.5%
0.00%
-100.0%
Q2 2023$1,051,884
-13.8%
219,600
+2.1%
0.00%0.0%
Q1 2023$1,219,617
-9.1%
215,100
-10.3%
0.00%0.0%
Q4 2022$1,342,320
-10.2%
239,700
+3.0%
0.00%0.0%
Q3 2022$1,495,000
+188.1%
232,800
+53.8%
0.00%
Q2 2022$519,000
-55.3%
151,400
-7.1%
0.00%
-100.0%
Q1 2022$1,160,000
-7.6%
162,900
+8.0%
0.00%0.0%
Q4 2021$1,256,000
+19.6%
150,8000.0%0.00%0.0%
Q3 2021$1,050,000
-70.8%
150,8000.0%0.00%
-50.0%
Q2 2021$3,597,000
+19.7%
150,800
+3.4%
0.00%0.0%
Q1 2021$3,004,000
-11.7%
145,900
+5.1%
0.00%0.0%
Q4 2020$3,401,000
+1271.4%
138,800
+284.5%
0.00%
Q1 2019$248,000
+52.1%
36,1000.0%0.00%
Q4 2018$163,000
-36.1%
36,100
+7.4%
0.00%
Q3 2018$255,000
-11.8%
33,6000.0%0.00%
Q2 2018$289,000
+17.0%
33,6000.0%0.00%
Q1 2018$247,000
-27.6%
33,6000.0%0.00%
Q4 2017$341,000
-36.7%
33,6000.0%0.00%
-100.0%
Q3 2017$539,000
+41.8%
33,6000.0%0.00%
Q2 2017$380,000
+42.3%
33,600
+41.8%
0.00%
Q1 2017$267,000
+13.6%
23,7000.0%0.00%
Q4 2016$235,000
-19.2%
23,7000.0%0.00%
Q3 2016$291,000
-57.7%
23,7000.0%0.00%
-100.0%
Q2 2016$688,000
+101.8%
23,700
+76.9%
0.00%0.0%
Q1 2016$341,000
-4.7%
13,400
+31.4%
0.00%0.0%
Q4 2015$358,00010,2000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders